ArticleBlood advances2022

Vemurafenib acts as a molecular on-off switch governing systemic inflammation in Langerhans cell histiocytosis.

Sebastian K Eder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.